https://www.thebodypro.com/category/providing-quality-hiv-care/tag/research

The Latest

pulling back curtain

This Week in HIV Research: Life in the Integrase Era

Aug. 6, 2020: Recent trends in drug interaction rates; integrase inhibitors and cardiac event risk; a deep dive into HIV drug resistance in Florida; frailty symptoms and neurocognitive disorders amidst high CD4 counts.

By Barbara Jungwirth and Myles Helfand
mental connection

This Week in HIV Research: The Mind Matters

July 23, 2020: Depression and HIV risk mitigation among MSM; a consistent HIV provider is good for CD4 and viral load; spirituality and HIV prevention; HCV treatment access and reinfection risk.

By Barbara Jungwirth and Myles Helfand
links in chain

This Week in HIV Research: Links in a Chain

July 16, 2020: Starting HIV treatment during hospitalization for people who use drugs; type of substance use affects viral suppression odds; benefits of a cross-disciplinary medical support team; does STI recency dictate PrEP necessity for women?

By Barbara Jungwirth and Myles Helfand
Ricardo Diaz, M.D. (top left) shares findings regarding a potential new HIV remission case in a virtual press conference during the 23rd International AIDS Conference on July 7, 2020.

HIV Clinical Research Highlights From AIDS 2020, the 23rd International AIDS Conference

COVID-19 or no, there was still plenty to learn at this year's virtual conference, including for U.S. clinicians seeking to improve the care and treatment they provide to their patients living with HIV.

By Myles Helfand
COVID-19 hospitalization

Still No Clear Indication That HIV Status Affects COVID-19 Severity

A pair of presentations at AIDS 2020 provides some of the largest studies to date on COVID-19 among people with HIV, but leaves us with many questions about the interplay between the two viruses.

By Myles Helfand
long road ahead

This Week in HIV Research: Do As We Say, Not As We Do

July 9, 2020: Abysmal HIV testing rates in U.S. ambulatory care settings; STI testing frequency in PrEP users; trends in U.S. PrEP uptake; integrating opioid therapy with HCV care in people who inject drugs.

By Barbara Jungwirth and Myles Helfand
slacklining

This Week in HIV Research: So Many Relative Risks

July 1, 2020: Quantifying bone fracture risks; real-world lipid effects of switching to TAF; pulmonary function impairment in MSM; immunomodulatory drugs and viral load blips.

By Barbara Jungwirth and Myles Helfand
bridging the chasm

This Week in HIV Research: Closing Our Care Chasms

June 25, 2020: 25 years of HOPS; successes of San Francisco’s test-and-treat program; missed opportunities to test people who inject drugs; how patient-provider trust can curb prescribing cascades.

By Barbara Jungwirth and Myles Helfand
white man black man

This Week in HIV Research: Existing Solutions Won't Close the Race Gap

June 18, 2020: Existing evidence-based interventions aren't enough to close HIV's racial gap; transgender patient outcomes in the HIV care continuum; meeting long-term needs of formerly incarcerated people; acute respiratory illness severity and HIV status.

By Barbara Jungwirth and Myles Helfand
raising the bar

This Week in HIV Research: Setting a New Bar

June 11, 2020: Diagnosis rates within a year of infection; rates of intentional non-daily PrEP use; neurological development in children of birth parents with HIV; point-of-care urine test to assess tenofovir levels.

By Barbara Jungwirth and Myles Helfand